Clinical Trials Directory

Trials / Conditions / Mucinous Adenocarcinoma of the Colon

Mucinous Adenocarcinoma of the Colon

19 registered clinical trials studyying Mucinous Adenocarcinoma of the Colon.

StatusTrialSponsorPhase
TerminatedNivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors
NCT03693846
Abramson Cancer Center at Penn MedicinePhase 2
TerminatedIrinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Sprea
NCT02110953
Fox Chase Cancer CenterPhase 1
WithdrawnZiv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With St
NCT02235324
University of Southern CaliforniaPhase 2
CompletedCPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg
NCT02232152
Wake Forest University Health SciencesPhase 1
TerminatedTelomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot
NCT01934179
Fox Chase Cancer Center—
CompletedIrinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
NCT01923337
University of California, DavisPhase 1
CompletedPanitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
NCT01814501
John HaysPhase 2
CompletedAdherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect
NCT01726296
Fox Chase Cancer CenterN/A
CompletedAflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
NCT01652196
John HaysPhase 2
WithdrawnCholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
NCT01403103
Case Comprehensive Cancer CenterEARLY_Phase 1
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
TerminatedChemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal
NCT01285102
Fox Chase Cancer CenterPhase 1
TerminatedCetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surg
NCT00835679
National Cancer Institute (NCI)EARLY_Phase 1
CompletedPhase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
NCT00100841
National Cancer Institute (NCI)Phase 2
CompletedA Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an
NCT00060411
National Cancer Institute (NCI)Phase 1
TerminatedGefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
NCT00052585
National Cancer Institute (NCI)Phase 2
CompletedIrinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00005036
National Cancer Institute (NCI)Phase 3
TerminatedPhase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
NCT00002796
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedEdrecolomab in Treating Patients With Stage II Colon Cancer
NCT00002968
National Cancer Institute (NCI)Phase 3